SMS Pharmaceuticals is currently trading at Rs. 88.00, up by 0.15 points or 0.17% from its previous closing of Rs. 87.85 on the BSE.
The scrip opened at Rs. 87.75 and has touched a high and low of Rs. 88.00 and Rs. 85.00 respectively. So far 3678 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 150.50 on 19-Oct-2021 and a 52 week low of Rs. 71.00 on 17-Jun-2022.
Last one week high and low of the scrip stood at Rs. 91.35 and Rs. 85.00 respectively. The current market cap of the company is Rs. 744.94 crore.
The promoters holding in the company stood at 64.17%, while Institutions and Non-Institutions held 0.63% and 35.20% respectively.
SMS Pharmaceuticals has acquired 4.9% stake by investing Rs 9,80,000 in Provenio Astral International LLP (Formerly Known as Studiom Square LLP).
This strategic partnership may help the company to expand its business in overseas and also If the company wish to establish any facility in overseas in future. This partnership will benefit to procure established connectivity facility with lesser price than the market.
SMS Pharmaceuticals is a global player in API and intermediates manufacturing having a strong research and manufacturing team supported by state?of?the?art facilities.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: